Amended Statement of Beneficial Ownership (sc 13d/a)

Date : 02/14/2020 @ 10:35PM
Source : Edgar (US Regulatory)
Stock : Mirati Therapeutics Inc (MRTX)
Quote : 83.47  -5.25 (-5.92%) @ 7:10PM
Mirati Therapeutics share price Chart

Amended Statement of Beneficial Ownership (sc 13d/a)

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

Under the Securities Exchange Act of 1934

(Amendment No. 15)*

 

 

Mirati Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

60468T105

(CUSIP Number)

David A. Brown

Alston & Bird LLP

950 F Street, N.W.

Washington, DC 20004-1404

202-239-3463

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

February 13, 2020

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


  1    

  NAMES OF REPORTING PERSONS

 

  Boxer Capital, LLC

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  WC

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  0

  8     

  SHARED VOTING POWER

 

  2,257,317*

  9     

  SOLE DISPOSITIVE POWER

 

  0

  10     

  SHARED DISPOSITIVE POWER

 

  2,257,317*

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  2,257,317*

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  4.8%**

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  OO

 

*

This number includes 491,757 shares of Common Stock that Boxer Capital has the right to acquire pursuant to the Boxer 2017 Warrant.

**

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Boxer Asset Management Inc.

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  WC

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Bahamas

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  0

  8     

  SHARED VOTING POWER

 

  2,257,317*

  9     

  SOLE DISPOSITIVE POWER

 

  0

  10     

  SHARED DISPOSITIVE POWER

 

  2,257,317*

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  2,257,317*

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  4.8%**

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  CO

 

*

This number includes 491,757 shares of Common Stock that Boxer Capital has the right to acquire pursuant to the Boxer 2017 Warrant.

**

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  MVA Investors, LLC

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  WC

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  253,338

  8     

  SHARED VOTING POWER

 

  0

  9     

  SOLE DISPOSITIVE POWER

 

  253,338

  10     

  SHARED DISPOSITIVE POWER

 

  0

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  253,338

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  0.5%*

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  OO

 

*

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Braslyn Ltd.

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  WC

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Bahamas

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  0

  8     

  SHARED VOTING POWER

 

  6,510,966*

  9     

  SOLE DISPOSITIVE POWER

 

  0

  10     

  SHARED DISPOSITIVE POWER

 

  6,510,966*

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  6,510,966*

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  13.9%**

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  CO

 

*

This number includes 3,375,000 shares of Common Stock that Braslyn has the right to acquire pursuant to the Braslyn 2017 Warrant.

**

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Aaron I. Davis

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  OO

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  62,163

  8     

  SHARED VOTING POWER

 

  253,388

  9     

  SOLE DISPOSITIVE POWER

 

  62,163

  10     

  SHARED DISPOSITIVE POWER

 

  253,388

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  315,551

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  0.7%*

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  IN

 

*

This number includes 23,111 shares of Common Stock subject to options exercisable within the next 60 days.

**

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Shehan B. Dissanayake

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  OO

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  203,754

  8     

  SHARED VOTING POWER

 

  0

  9     

  SOLE DISPOSITIVE POWER

 

  203,754

  10     

  SHARED DISPOSITIVE POWER

 

  0

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  203,754

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  0.4%*

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  IN

 

*

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Christopher Fuglesang

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  OO

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  30,518

  8     

  SHARED VOTING POWER

 

  0

  9     

  SOLE DISPOSITIVE POWER

 

  30,518

  10     

  SHARED DISPOSITIVE POWER

 

  0

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  30,518

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  0.1%*

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  IN

 

*

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Ivan M. Lieberburg

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  OO

  5    

  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  37,241

  8     

  SHARED VOTING POWER

 

  0

  9     

  SOLE DISPOSITIVE POWER

 

  37,241

  10     

  SHARED DISPOSITIVE POWER

 

  0

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  37,241

12    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  0.1%*

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  IN

 

*

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

  1    

  NAMES OF REPORTING PERSONS

 

  Joe Lewis

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)  ☒        (b)  ☐

 

  3    

  SEC USE ONLY

 

  4    

  SOURCE OF FUNDS (See Instructions)

 

  WC

  5    

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United Kingdom

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    7     

  SOLE VOTING POWER

 

  0

  8     

  SHARED VOTING POWER

 

  8,768,283*

  9     

  SOLE DISPOSITIVE POWER

 

  0

  10     

  SHARED DISPOSITIVE POWER

 

  8,768,283*

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  8,768,283*

12    

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

 

  ☐

13    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  18.7%**

14    

  TYPE OF REPORTING PERSON (See Instructions)

 

  IN

 

*

This number includes (i) 491,757 shares of Common Stock that Boxer Capital has the right to acquire pursuant to the Boxer 2017 Warrant and (ii) 3,375,000 shares of Common Stock that Braslyn has the right to acquire pursuant to the Braslyn 2017 Warrant.

**

Based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

This Amendment No. 15 (“Amendment No. 15”) amends and supplements the statement on Schedule 13D filed on November 4, 2013 (the “Original Filing”) by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”), MVA Investors, LLC (“MVA Investors”) and Joe Lewis, as amended by Amendment No. 1 filed on February 2, 2015, Amendment No. 2 filed on September 18, 2015, Amendment No. 3 filed on January 6, 2016 (“Amendment No. 3”), Amendment No. 4 filed on January 15, 2016 (“Amendment No. 4”), Amendment No. 5 filed on March 17, 2016, Amendment No. 6 filed on June 8, 2016, Amendment No. 7 filed on June 24, 2016, Amendment No. 8 filed on September 28, 2016, Amendment No. 9 filed on January 10, 2017, Amendment No. 10 filed on January 30, 2017, Amendment No. 11 filed on June 27, 2017, Amendment No. 12 filed on November 20, 2017, Amendment No. 13 filed on May 23, 2019 and Amendment No. 14 filed on July 19, 2019. Amendment No. 3 was an original filing for Braslyn Ltd. (“Braslyn”). Amendment No. 4 was an original filing for Aaron I. Davis, Shehan B. Dissanayake, Christopher Fuglesang, Rodney W. Lappe, Ivan M. Lieberburg and Neil Reisman. Boxer Capital, Boxer Management, MVA Investors, Braslyn, Joe Lewis, Aaron I. Davis, Shehan B. Dissanayake, Christopher Fuglesang and Ivan M. Lieberburg are collectively referred to herein as the “Reporting Persons.” The Original Filing, as amended, remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 15. Capitalized terms used and not defined in this Amendment No. 15 have the meanings set forth in the Original Filing, as amended.

This Amendment No. 15 is being filed due to a change in the organizational structure of MVA Investors that gives Aaron I. Davis voting and dispositive power over the securities held by MVA Investors.

Item 5. Interest in Securities of the Issuer.

Item 5 is hereby amended and restated in its entirety as follows:

All percentages are based on 46,796,013 shares of Common Stock outstanding which is the sum of (i) 42,906,145 shares of Common Stock reported to be outstanding according to the Issuer’s Prospectus Supplement filed with the SEC on January 10, 2020, (ii) 491,757 shares of Common Stock, which Boxer Capital currently has the right to acquire pursuant to the Boxer 2017 Warrant, (iii) 3,375,000 shares of Common Stock, which Braslyn currently has the right to acquire pursuant to the Braslyn 2017 Warrant, and (iv) 23,111 shares of Common Stock subject to options exercisable within the next 60 days.

(a) The Reporting Persons may be deemed to beneficially own, in the aggregate, 9,355,297 shares of Common Stock, representing 19.99% of the Issuer’s outstanding Common Stock.

Boxer Capital and Boxer Management beneficially own 2,257,317 shares of Common Stock which represents 4.8% of the Issuer’s outstanding Common Stock. Braslyn beneficially owns 6,510,966 shares of Common Stock which represents 13.9% of the Issuer’s outstanding Common Stock. Joe Lewis beneficially owns 8,768,283 shares of Common Stock which represents 18.7% of the Issuer’s outstanding Common Stock. MVA Investors beneficially owns 253,338 shares of Common Stock which represents 0.5% of the Issuer’s outstanding Common Stock. Aaron I. Davis beneficially owns 315,551 shares of Common Stock, which includes 23,111 shares of Common Stock subject to options exercisable within the next 60 days, and represents 0.7% of the Issuer’s outstanding Common Stock. Shehan B. Dissanayake beneficially owns 203,754 shares of Common Stock which represents 0.4% of the Issuer’s outstanding Common Stock. Christopher Fuglesang beneficially owns 30,518 shares of Common Stock which represents 0.1% of the Issuer’s outstanding Common Stock. Ivan M. Lieberburg beneficially owns 37,241 shares of Common Stock which represents 0.1% of the Issuer’s outstanding Common Stock.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

The table below reflects options to purchase shares of Common Stock of the Issuer owned by Aaron I. Davis that are not currently exercisable within the next 60 days:

 

Grant Date

 

Number of

Non-Vested

Options

  

Vesting Schedule

12/6/2018

  13,889   

Exercisable in 36 equal monthly installments following the date of grant

1/3/2020

  3,000   

Exercisable in 12 equal monthly installments following the date of grant

The 2017 Warrants represent a right for Boxer Capital, MVA Investors and Braslyn to purchase 491,757, 51,047 and 4,590,426 shares of Common Stock, respectively. The 2017 Warrants have been pre-paid at a price of $5.599 per share with an exercise price of $0.001 per share. The 2017 Warrants are only exercisable to the extent that the holders thereof and their affiliates would beneficially own no more than 19.99% of the outstanding Common Stock after exercise.

The November 2017 Warrants represent a right for Boxer Capital and Braslyn to purchase 801,448 and 1,413,475 shares of Common Stock, respectively. The November 2017 Warrants have been pre-paid at a price of $12.999 per share with an exercise price of $0.001 per share. The November 2017 Warrants are only exercisable to the extent that the holders thereof and their affiliates would beneficially own no more than 19.99% of the outstanding Common Stock after exercise.

(b) With respect to any rights or powers to vote, or to direct the vote of, or to dispose of, or direct the disposition of, the Common Stock owned by the Reporting Persons:

(i) Sole power to vote or direct the vote:

Aaron I. Davis has the sole power to vote the 62,163 shares of Common Stock he beneficially owns. Shehan B. Dissanayake has the sole power to vote the 203,754 shares of Common Stock he beneficially owns. Christopher Fuglesang has the sole power to vote the 30,518 shares of Common Stock he beneficially owns. Ivan M. Lieberburg has the sole power to vote the 37,241 shares of Common Stock he beneficially owns.

(ii) Shared power to vote or to direct the vote:

Boxer Capital and Boxer Management have shared voting power with respect to the 2,257,317 shares of Common Stock they beneficially own. Braslyn has shared voting power with respect to the 6,510,966 shares of Common Stock it beneficially owns. Joe Lewis has shared voting power with respect to the 8,768,283 shares of Common Stock he beneficially owns. MVA Investors and Aaron Davis have shared voting power with respect to the 253,338 shares of Common Stock they beneficially own.

(iii) Sole power to dispose or direct the disposition of:

Aaron I. Davis has the sole power to dispose of the 62,163 shares of Common Stock he beneficially owns. Shehan B. Dissanayake has the sole power to dispose of the 203,754 shares of Common Stock he beneficially owns. Christopher Fuglesang has the sole power to dispose of the 30,518 shares of Common Stock he beneficially owns. Ivan M. Lieberburg has the sole power to dispose of the 37,241 shares of Common Stock he beneficially owns.

(iv) Shared power to dispose or to direct the disposition of:

Boxer Capital and Boxer Management have shared dispositive power with respect to the 2,257,317 shares of Common Stock they beneficially own. Braslyn has shared dispositive power with respect to the 6,510,966 shares of Common Stock it beneficially owns. Joe Lewis has shared dispositive power with respect to the 8,768,283 shares of Common Stock he beneficially owns. MVA Investors and Aaron Davis have shared dispositive power with respect to the 253,338 shares of Common Stock they beneficially own.

(c) The Reporting Persons have not engaged in any transactions in the Common Stock in the past 60 days.    

(d) No other person has the right to receive or the power to direct the receipt of dividends, or proceeds of sale of such securities outlined in this report.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Except as otherwise described in the Original Filing, as amended, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies

Item 7. Material to Be Filed as Exhibits.

 

Exhibit 1    Joint Filing Agreement, dated July 19, 2019, among Boxer Capital, Boxer Management, Braslyn, MVA Investors, Joe Lewis, Aaron I. Davis, Shehan B. Dissanayake, Christopher Fuglesang, and Ivan M. Lieberburg.
Exhibit 2    Form of Warrant to Purchase Common Stock issued in connection with the January 2017 Offering, which is incorporated herein by reference to Exhibit 4.1 to the Form 8-K filed by the Issuer on January 6, 2017.
Exhibit 3    Form of Warrant to Purchase Common Stock issued in connection with the November 2017 Offering, which is incorporated herein by reference to Exhibit 4.1 to the Form 8-K filed by the Issuer on November 16, 2017.
Exhibit 4    Limited Power of Attorney, dated May 23, 2019, by and between Ivan M. Lieberburg and Christopher Fuglesang.


CUSIP No. 60468T105    SCHEDULE 13D/A   

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2020

 

BOXER CAPITAL, LLC

By:

  /s/ Aaron I. Davis

Name:

  Aaron I. Davis

Title:

  Chief Executive Officer

BOXER ASSET MANAGEMENT INC.

By:

  /s/ Jason Callender

Name:

  Jason Callender

Title:

  Director

BRASLYN LTD.

By:

  /s/ Joseph C. Lewis

Name:

  Joseph C. Lewis

Title:

  Director

MVA INVESTORS, LLC

By:

  /s/ Aaron I. Davis

Name:

  Aaron I. Davis

Title:

  Authorized Signatory

JOSEPH C. LEWIS

By:

  /s/ Joseph C. Lewis
  Joseph C. Lewis, Individually

IVAN M. LIEBERBURG

By:

  /s/ Christopher Fuglesang
  Christopher Fuglesang, Attorney-in-Fact*

AARON I. DAVIS

By:

  /s/ Aaron I. Davis
  Aaron I. Davis, Individually

SHEHAN B. DISSANAYAKE

By:

  /s/ Shehan B. Dissanayake
  Shehan B. Dissanayake, Individually

CHRISTOPHER FUGLESANG

By:

  /s/ Christopher Fuglesang
  Christopher Fuglesang, Individually

 

*

This Schedule 13D and the Joint Filing Agreement attached as Exhibit 1 hereto were executed by Christopher Fuglesang on behalf of Ivan M. Lieberburg pursuant to the Limited Power of Attorney attached as Exhibit 4 hereto.


EXHIBIT INDEX

 

Exhibit 1    Joint Filing Agreement, dated July 19, 2019, among Boxer Capital, Boxer Management, Braslyn, MVA Investors, Joe Lewis, Aaron I. Davis, Shehan B. Dissanayake, Christopher Fuglesang and Ivan M. Lieberburg.
Exhibit 2    Form of Warrant to Purchase Common Stock issued in connection with the January 2017 Offering, which is incorporated herein by reference to Exhibit 4.1 to the Form 8-K filed by the Issuer on January 6, 2017.
Exhibit 3    Form of Warrant to Purchase Common Stock issued in connection with the November 2017 Offering, which is incorporated herein by reference to Exhibit 4.1 to the Form 8-K filed by the Issuer on November 16, 2017.
Exhibit 4    Limited Power of Attorney, dated May 23, 2019, by and between Ivan M. Lieberburg and Christopher Fuglesang.

Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more Mirati Therapeutics Charts.

Mirati Therapeutics (NASDAQ:MRTX)
Intraday Stock Chart

Today : Tuesday 25 February 2020

Click Here for more Mirati Therapeutics Charts.

Latest MRTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200225 19:25:11